PRODUCT MONOGRAPH. PR. Cathflo. ® alteplase, recombinant . cell line into which the cDNA for alteplase has been genetically inserted. Read all of this leaflet carefully before you What Actilyse Cathflo is and what it is used for. 2. Contents of the pack and other information. 1. Drug monographs for CATHFLO ACTIVASE provide an overview of the drug Keeping the vial of Sterile Water for Injection upright, insert the piercing pin of the .
|Published (Last):||14 April 2013|
|PDF File Size:||17.89 Mb|
|ePub File Size:||12.51 Mb|
|Price:||Free* [*Free Regsitration Required]|
Severe Coadministration of defibrotide with fibrinolytics thrombolytic agents is contraindicated.
Slight foaming is not unusual; let the vial stand undisturbed to allow large bubbles to dissipate. Click “OK” if you are a knsert professional.
Withdraw 2 mL 2 mg of solution from the reconstituted vial. Aminosalicylate sodium, Aminosalicylic acid: Insert the spike end of an infusion set through the same puncture site created by the transfer device in the stopper of the vial of reconstituted alteplase. Genentech will not contact the individuals you share content with. Remove the protective cap from a vial of alteplase and hold it upside-down over the piercing pin of the transfer device.
Wible and his expert author team provide carefully updated information in a concise, bulleted format, keeping you current with recent advances in interventional radiology. We now just follow the manufacturer’s recommendations of 30 minutes to 2 hours of indwelling time. If it shows that placement is correct then we get a Md order to proceed.
Administer antihypertensive medications to maintain blood pressure at or below these values. Remove the appropriate indication-specific volume from the reconstituted vial using a syringe and needle. We have a few patients who are fibrin producers, so form the sheath.
Dosage & Administration – Cathflo® Activase® (alteplase)
Children weighing 10 to 29 kg. Studies have only evaluated up to two 2-mg doses. Your email has been sent. Moderate Increased effects from concomitant anticoagulant drugs including increased bruising or blood in the stool have been reported in patients taking methylsulfonylmethane, MSM.
Cathflo should be vathflo immediately before use. The risks of alteplase therapy may be increased in patients with significant hepatic impairment and should be weighed against the anticipated benefits.
Patients should be closely monitored for signs and symptoms of bleeding when a thrombolytic agent is administered with vortioxetine and instructed to promptly report any bleeding events to the practitioner. Unsert dosing with Cathflo 8. Get useful tools to help you ensure and promote patency in your clinical practice. Monitor patients treated with Cathflo Activase for signs of hypersensitivity and treat appropriately if necessary.
In patients isnert acute ischemic stroke with uncontrolled hypertension who are otherwise eligible for alteplase therapy, increase the insret of blood pressure monitoring if systolic blood pressure is more than mmHg or diastolic blood pressure is more than mmHg.
Powered by Higher Logic.
All ONS Member Community
After ginkgo was stopped, no further bleeding was noted despite cahhflo the aspirin therapy. Patients were randomized to receive a 4-week treatment period of either placebo or 3 or 6 grams of fish oil daily.
Both forms have similar fibrinolytic and plasminogen-activating potential; however, the one-chain alteplase is considerably less active in the absence of fibrin. It is possible that the use of green tea may increase the risk of bleeding if coadministered cathrlo thrombolytic agents.
Cathflo Activase (alteplase) dose, indications, adverse effects, interactions from
Theoretically, the risk of bleeding may be increased. If catheter function is not restored at minutes after 1 dose of Cathflo, a second dose may be instilled see Instructions for Administration. Consider other reasons for catheter dysfunction, such as catheter malposition, mechanical failure, constriction by a suture, and lipid deposits or drug precipitates within the lumen, before treatment with alteplase. Alteplase is approved for the management of occluded catheters in children and infants.
It is reasonable to administer fibrinolytic therapy within 24 hours of the onset of STEMI symptoms in patients who have continuing ischemic symptoms and ST elevation greater than 0.
The reconstituted preparation results in a colorless to pale yellow transparent solution at a pH of approximately 7. Alteplase is indicated for the treatment of acute ischemic stroke, for improving packahe recovery and reducing the incidence of disability; initiate treatment within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage by a cranial computerized tomography CT scan or other diagnostic imaging method sensitive for the presence of hemorrhage.
Related Drug Information Drug Summary. In clinical trials, the most serious adverse events reported after treatment were sepsis, gastrointestinal bleeding, and venous thrombosis.
Monitor patients treated with Cathflo Activase for signs of hypersensitivity and treat appropriately if necessary.
Patients should be closely monitored for signs and symptoms of bleeding when a thrombolytic agent is administered with vilazodone. In my experience, one hour dwell is what we usually need.